The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Examining molecular landscape and drug sensitivity profiles of patient-derived xenografts from resected brain metastases.
 
Aki Morikawa
Consulting or Advisory Role - Eisai; Lilly; Seagen
Research Funding - Dantari Pharmaceuticals (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); F. Hoffmann LaRoche (Inst); Freenome (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck Sharp & Dohme Corp. (Inst); Merrimack (Inst); Millenium Pharamceuticals (Inst); Molecular Templates (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Suzhou Zanrong Pharma (Inst); Tempus (Inst)
Other Relationship - Taiho Pharmaceutical
(OPTIONAL) Uncompensated Relationships - Puma Biotechnology
 
Tusharika Rastogi
No Relationships to Disclose
 
Peter Ulintz
No Relationships to Disclose
 
Habib Serhan
No Relationships to Disclose
 
Edwin Nieblas-Bedolla
No Relationships to Disclose
 
Jason Heth
No Relationships to Disclose
 
Xu Cheng
No Relationships to Disclose
 
Liwei Bao
No Relationships to Disclose
 
Aaron M. Udager
No Relationships to Disclose
 
Matthew Soellner
Research Funding - Nuvalent, Inc.
 
Nathan Merrill
No Relationships to Disclose
 
Sofia Diana Merajver
No Relationships to Disclose